Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID Model
VCID 模型中慢性远程缺血条件诱导脑保护的机制
基本信息
- 批准号:9382326
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAgeAreaBilateralBiological AvailabilityBiological PreservationBlood PressureBlood VesselsBone MarrowBone Marrow CellsBrainBrain-Derived Neurotrophic FactorCarotid StenosisCellsCerebral small vessel diseaseCerebrovascular CirculationCerebrovascular systemChimera organismChronicCognitionCognitive deficitsDataDementiaDependenceDistantEconomic InflationEndocrineEndotheliumEventExerciseFoundationsGoalsGrowthHumanHypoxiaImpaired cognitionInflammationInterventionIntracranial AtherosclerosesIschemic Brain InjuryKnock-outKnockout MiceLegLimb structureMediatingModelingMusNOS3 geneNational Institute of Neurological Disorders and StrokeNitritesObservational StudyOrganPathologicPatientsPeripheralPhenotypePhysical ExercisePlasmaPrevalenceProtein KinaseProteinsPublic HealthRisk FactorsRoleStem cellsStrokeTestingTranslatingVascular DementiaVascular remodelingWorkabeta accumulationacronymsage effectangiogenesisarmbench to bedsideblood vessel developmentcognitive performanceconditioningeffective therapyimprovedmimeticsmouse modelnervous system disorderneurovascular unitnovelsexshear stresssoundvascular cognitive impairment and dementiawhite matter damage
项目摘要
The prevalence of dementia is expected to triple by 2050 making it a major threat to world public health. Vascular
dementia makes up 20% of dementia cases and vascular causes contribute to another 30%. These vascular
contributions to cognitive impairment and dementia are known by the acronym VCID. There is no known effective
treatment for VCID; however observational studies strongly suggest that physical exercise is effective at reducing
progression of cognitive decline and dementia. Chronic remote ischemic conditioning (C-RIC), is the
repetitive inflation and deflation of a blood pressure cuff on the limbs for periods of weeks or months and may
be an “exercise mimetic”. Our data in the VCID mouse model shows that C-RIC is cerebroprotective, increasing
cerebral blood flow and collateral remodeling and improving cognition.
Our central hypothesis is that C-RIC triggers a cerebroprotective phenotype by activation of peripheral
limb AMPK and eNOS with an increase in circulating plasma nitrite and “endocrine NO activity”
leading to increased CBF, angiogenesis, and collateral remodeling. Our sub-hypothesis is that these effects
of C-RIC are age and sex independent.
Our Specific aims are:
Aim 1: Determine the critical role of eNOS in mediating C-RIC induced cerebroprotection and vascular
remodeling upon eNOS.
Aim 2: Determine the dependence of C-RIC cerebroprotection upon endothelial- specific AMPK1, an upstream
regulator of eNOS. We will utilize an endothelial specific AMPKα mouse knockout (KO) model to determine
whether RIC’s protection is dependent upon endothelial AMPKα1.
Aim 3: Determine the role of bone marrow (BM) -derived cells in C-RIC-induced angiogenesis and collateral
remodeling. eNOS in BM cells may be critical to the mechanism of C-RIC.
These studies will help us to define the mechanism of C-RIC in cerebroprotection and help us translate C-RIC
from the bench to the bedside in patients with VCID to reduce dementia.
预计到2050年,痴呆症的患病率将增加两倍,成为世界公共卫生的主要威胁。血管
痴呆症占痴呆症病例的20%,血管原因占另外30%。这些血管
对认知损害和痴呆的贡献已知为首字母缩写VCID。没有已知的有效
治疗VCID;然而,观察性研究强烈表明,体育锻炼是有效的,
认知能力下降和痴呆症的进展。慢性远程缺血性条件反射(C-RIC)是一种
血压袖带在肢体上的重复充气和放气达数周或数月的时间段,并且可能
做一个“运动模拟器”。我们在VCID小鼠模型中的数据显示,C-RIC具有抗肿瘤保护作用,
改善脑血流和侧支重塑,改善认知功能。
我们的中心假设是,C-RIC通过激活外周血淋巴细胞,
肢体AMPK β和eNOS与循环血浆亚硝酸盐和“内分泌NO活性”的增加
导致CBF增加、血管生成和侧支重塑。我们的子假设是这些效应
C-RIC与年龄和性别无关。
我们的具体目标是:
目的1:确定eNOS在介导C-RIC诱导的血管保护和血管内皮细胞凋亡中的重要作用。
重塑eNOS。
目的2:确定C-RIC对内皮特异性AMPK β 1的依赖性,AMPK β 1是内皮细胞的上游保护因子。
eNOS的调节剂。我们将利用内皮特异性AMPKα敲除小鼠(KO)模型来确定
RIC的保护作用是否依赖于内皮AMPKα1。
目的3:确定骨髓(BM)源性细胞在C-RIC诱导的血管生成和侧支循环中的作用
重塑BM细胞中的eNOS可能在C-RIC的机制中起关键作用。
这些研究将有助于我们明确C-RIC在脑保护中的作用机制,并帮助我们翻译C-RIC
从实验室到床旁,在VCID患者中减少痴呆症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID C. HESS其他文献
DAVID C. HESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID C. HESS', 18)}}的其他基金
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)
中风和远程缺血调节 (REDS) 中的红细胞分泌功能障碍
- 批准号:
10335203 - 财政年份:2020
- 资助金额:
$ 38万 - 项目类别:
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)
中风和远程缺血调节 (REDS) 中的红细胞分泌功能障碍
- 批准号:
10565864 - 财政年份:2020
- 资助金额:
$ 38万 - 项目类别:
Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectant
远程缺血调理:并行治疗和神经保护剂
- 批准号:
10221786 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID Model
VCID 模型中慢性远程缺血条件诱导脑保护的机制
- 批准号:
9752676 - 财政年份:2017
- 资助金额:
$ 38万 - 项目类别:
Remote ischemic conditioning for neuroprotection in vascular cognitive impairment
远程缺血调理对血管性认知障碍的神经保护作用
- 批准号:
8986013 - 财政年份:2015
- 资助金额:
$ 38万 - 项目类别:
Remote Ischemic Conditioning:Translating Endogenous Neuroprotection in Embolic St
远程缺血调理:栓塞治疗中的内源性神经保护
- 批准号:
8634820 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Remote Ischemic Conditioning:Translating Endogenous Neuroprotection in Embolic St
远程缺血调理:栓塞治疗中内源性神经保护的转化
- 批准号:
8528909 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Minocycline to Improve Neurologic Outcome (MINO Clinical Trial)
米诺环素改善神经系统结果(MINO 临床试验)
- 批准号:
7591163 - 财政年份:2007
- 资助金额:
$ 38万 - 项目类别:
Minocycline to Improve Neurologic Outcome (MINO Clinical Trial)
米诺环素改善神经系统结果(MINO 临床试验)
- 批准号:
7265406 - 财政年份:2007
- 资助金额:
$ 38万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 38万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 38万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 38万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 38万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Studentship Programs














{{item.name}}会员




